TAO Synergies Inc. (TAOX) Stock
Healthcare · Biotechnology · US
$3.94
-21.83%
Last updated Jun 18, 2026 23:57 UTC
TAOX Key Statistics
Market Cap$12.95M
P/E (TTM)-0.31
P/S (TTM)43.29
P/B (TTM)0.33
Revenue (TTM)$299,061.00
EPS (TTM)$-12.70
Dividend Yield—
ROE (TTM)-182.52%
Net Margin-9,609.23%
Gross Margin100.00%
52W High$7.15
52W Low$3.74
Analyst View—
Price Target—
Employees4
Volume824,162
About TAO Synergies Inc.
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
CEO: Joshua N. Silverman. Company website
See TAOX live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open TAOX in Terminal See plans